Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum - Top-Institutions - MDSpire

Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum

  • By

  • Andrea Mastrangelo

  • Angela Mammana

  • Sara Hall

  • Erik Stomrud

  • Corrado Zenesini

  • Marcello Rossi

  • Shorena Janelidze

  • Alice Ticca

  • Sebastian Palmqvist

  • Franco Magliocchetti

  • Simone Baiardi

  • Niklas Mattsson-Carlgren

  • Oskar Hansson

  • Piero Parchi

  • December 17, 2024

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Memory and Aging Center
    University of California, San Francisco (UCSF) Memory and Aging Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Biomarker Research

  • #2

    Mayo Clinic, Rochester
    Mayo Clinic, Rochester

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neurodegeneration
    • Clinical Biomarkers

  • #3

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, N/A

    Key Differentiators

    • Neurology
    • Neurodegenerative Disease Research
    • Biomarker Development

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neurodegenerative Disorders
    • Molecular Biomarkers

  • #5

    Massachusetts General Hospital (MGH) - Harvard Medical School
    Massachusetts General Hospital (MGH) - Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Neurodegenerative Disease
    • Biomarker Research

Original Source(s)

Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum

  • by Andrea Mastrangelo, Angela Mammana, Sara Hall, Erik Stomrud, Corrado Zenesini, Marcello Rossi, Shorena Janelidze, Alice Ticca, Sebastian Palmqvist, Franco Magliocchetti, Simone Baiardi, Niklas Mattsson-Carlgren, Oskar Hansson, Piero Parchi

  • December 17, 2024

Related Content

Complexity of fractal dimension patterns and machine learning-based classification of altered motor cortical oscillatory activity in rodent models of Parkinson disease

Stage-stratified benefits of AI-radiomics PET in early Alzheimer’s disease: a systematic review and meta-analysis

Baptist Health Miami Neuroscience Institute Advances Parkinson’s Disease Imaging With Specialized MRI Protocol

Diagnosing Parkinson’s disease has long depended primarily on clinical expertise — careful neurologic examination, longitudinal symptom assessment and the nuanced interpretation of movement abnormalities.

  • by

  • May 11, 2026

  • 5 min